A major news story from Sanofi this month is that "The European Medicines Agency has approved Dupixent (dupilumab ... ratios, ...

Also, since 2010, he is Full Member and Greece’s National representative in the CHMP Pharmacogenomics Working Party of the European Medicines Agency (EMA, Amsterdam, the Netherlands) and Co ...

The European Medicines Agency has said no to approving a new drug for Alzheimer's disease in the EU. Aducanumab does not appear to be effective at treating adults with early-stage symptoms ...

− Type II Variation Submission Based on the Positive HELIOS-B Phase 3 Study in which Vutrisiran Significantly Reduced the Risk of Death and Cardiovascular Events Relative to Placebo – "Today ...

Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...

Who can book their Covid vaccine now ... benefits of using it outweighed any risks of side-effects. The European Medicines Agency (EMA) came to the same conclusion after looking at a potential ...

Homeopaths claim that substances that can cause symptoms when given to generally healthy people can be used in tiny doses to ...

The public issue is a book-built offer worth Rs 10,000 crore ... of compliance for its Hyderabad-based biosimilars ...

Cantor and William Blair were joint book-running managers for ... Drug designation by the FDA, and by the European Commission, for the treatment of Idiopathic Hypersomnia, or IH. The U.S. Drug ...

Get the latest news on the transition to the new administration of President-elect Donald Trump and a new Congress.